Day: September 28, 2021

HOUSTON, Sept. 28, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid tumors, today announced the receipt of a $2.7 million payment under its existing contract with the Cancer Prevention and Research Institute of Texas (CPRIT). The payment is part of a non-dilutive grant that was originally awarded in 2016 to support Salarius’ operations and development of its lead drug candidate, seclidemstat. Seclidemstat (SP-2577) is a novel, oral tablet, reversible inhibitor of lysine-specific histone demethylase 1 (LSD1), an enzyme that plays a key role in the development and progression of several cancers. This latest disbursement of CPRIT funds is additive to the...

Mean weight loss of 10.3% achieved in subjects receiving 1.8 mg dose Pemvidutide was well-tolerated without the need for dose titration No discontinuations due to treatment-emergent adverse events NASH IND has cleared FDA review; 12-week NAFLD study to begin in the near future Altimmune to host a conference call today at 8:30 am ESTGAITHERSBURG, Md., Sept. 28, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced positive results from a 12-week, Phase 1 trial of pemvidutide (proposed INN, formerly known as ALT-801), an investigational glucagon-like peptide-1 (GLP-1)/glucagon dual receptor agonist. The Phase 1 study was a first-in-human, randomized, placebo-controlled, single ascending dose (SAD) and multiple ascending dose (MAD) study in overweight and obese volunteers...

Immunity enhanced silkworms provide licensing opportunities into the broader $14 B1 silk industry ANN ARBOR, Mich., Sept. 28, 2021 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces today that it is preparing to conduct challenge testing on two lines of immunity enhanced silkworms. These silkworm lines were developed by Kraig Labs to combat two of the biggest challenges facing the global silk production industry. It has been reported that as much as 50% of all losses in silk production result from a single widespread virus. A 2020 paper cited that 75% of all interviewer silkworm raisers reported losses due to this disease. With no effective treatment, this virus results in countless millions...

WALTHAM, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced that David Southwell, President and Chief Executive Officer, will participate in a virtual fireside chat at the Chardan 5th Annual Genetic Medicines Conference on Tuesday, October 5, 2021 at 2:00 p.m. ET. A live webcast of the fireside chat will be available on the “Events and Presentations” section of the Company’s website at ir.tscan.com. An archived replay of the webcast will be available on the Company’s website following the event. About TScan Therapeutics, Inc. TScan is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T...

Mr. Dahl Brings Over 25 Years of Financial and Operational Expertise to the Business VANCOUVER, British Columbia, Sept. 28, 2021 (GLOBE NEWSWIRE) — Billy Goat Brands Ltd. (the “Company” or “Billy Goat”) (CSE: GOAT), a venture capital platform focused on identifying, sponsoring and incubating environmental, social and governance (“ESG”) focused companies in the blue economy, is pleased to announce the appointment of Mr. Kris Dahl to the Board of Directors (the “Board”) of The Vegetarian Butcher (“TVB”). TVB operates in the plant-based meat sector with two retail locations in Kelowna and Vancouver, British Columbia. TVB is one of GOAT’s current investee companies and it plans to become the number one plant-based meat company in Canada, while curating high-quality vegan meat products and brands for consumers. Mr. Dahl is currently...

REDWOOD CITY, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced a new positive coverage decision from Cigna, expanding access to Aquablation therapy for the treatment of their members with Benign Prostatic Hyperplasia. The revised policy is effective September 15, 2021. Cigna Corporation is a global health service company that provides health insurance coverage for approximately 16 million members in the United States. Their mission is to improve the health, well-being, and peace of mind to those they serve by making health care simple, affordable, and predictable. “We are pleased with Cigna’s decision to cover Aquablation therapy for the treatment of lower urinary...

VANCOUVER, British Columbia, Sept. 28, 2021 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. and its 100% owned subsidiary Almadex Royalties Ltd., (collectively “Almadex” or the “Company”) (TSX-V: “DEX”) is pleased to announce that it has entered into a definitive agreement regarding the sale of the 2.0% NSR royalty on the Elk Gold Project, located near Merritt, B.C. (the “Elk Project”) to Star Royalties Ltd. (“Star Royalties”) (TSX-V: “STRR”) for total consideration of US$10.63 million (the “Transaction”). The consideration payable upon closing includes US$10 million in cash and the issuance to Almadex of 1,659,304 common shares of Star Royalties and 829,652 common share purchase warrants of Star Royalties exercisable for two years at $0.70 per common share. Mr. J. Duane Poliquin, Chairman of Almadex commented,...

Section includes 350.91 g Ag eq/t (112.57 g Ag/t, 1.41% Zn, 3.08% Pb and 0.33% Sn) over 30.06mTable 1Significant Diamond Drilling Results, Iska Iska, as at September 28, 2021Figure 1Geology of the Iska Iska Caldera Complex showing locations of Major Breccia Pipe targets including the magnetic anomaly northwest of the Santa Barbara Breccia Pipe and diamond drill holes completed and in progress.Figure 2SW-NE Geological Cross Section, Santa Barbara Breccia Pipe showing Location of Newly Released Drill Hole DHK-22 Relative to Discovery Hole DHK-15.TORONTO, Sept. 28, 2021 (GLOBE NEWSWIRE) — Eloro Resources Ltd. (TSX-V: ELO; OTCQX: ELRRF; FSE: P2QM) (“Eloro”, or the “Company”) is pleased to provide an update on its Iska Iska silver-tin polymetallic project in the Potosi Department,...

Figure 1Goudreau Project mapFigure 2Showing structures along the Baltimore Deformation ZoneSUDBURY, Ontario, Sept. 28, 2021 (GLOBE NEWSWIRE) — Manitou Gold Inc. (TSX-V: MTU) (the “Company” or “Manitou”) is pleased announce that it has identified a new gold zone, the Bald Eagle Gold Zone (the “BEGZ”) on its Goudreau project in northeastern Ontario. The BEGZ has been intersected with six drill holes over a strike length of 150 meters. Highlights:Visible gold observed in the BEGZ hole MTU-21-43 with assays pendingNew gold zone identified in the northeastern portion of the project area with wide drill intersections of gold mineralizationIntersection highlights of:3.3 g/t Au over 3.0 m, including 5.2 g/t Au over 1.5 m within a wider gold mineralized interval of 20.6 m at 0.8 g/t Au in hole MTU-21-41;...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES (All figures in Canadian dollars unless otherwise stated) TORONTO, Sept. 28, 2021 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd (TSXV: QGR, OTC: QGLDF, FRA: QX9G) (“Q-Gold” or the “Company”) is pleased to announce that it has closed the first tranche of its previously announced C$500,000 non-brokered financing (the “Offering”) for gross proceeds of C$250,000 (the “First Tranche”). Closing of the First Tranche and the Offering is subject to final approval of the TSX Venture Exchange. The proceeds of the First Tranche will be to fund the exploration work at the Surupana Property, as well as for general corporate and working capital purposes. Pursuant to the First Tranche, the Company issued 1,666,667 units of the Company (each a “Unit” and...